Fortress Biotech, Inc. (FBIO) vs Pliant Therapeutics, Inc. (PLRX)
- Fortress Biotech, Inc. FBIO 1.87 −2.09%
- Pliant Therapeutics, Inc. PLRX 0.90 −7.22%
Fortress Biotech, Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Pliant Therapeutics, Inc. are of similar size ($63.7M and $60.2M). Pliant Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −49.0%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 18 metrics below, Fortress Biotech, Inc. leads on 12 and Pliant Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | FBIO | PLRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 0.00% | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | (50.29%) | (56.36%) |
| Return on assets | 43.38% | (37.69%) | (48.04%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack